Hyperfine’s (HYPR) “Buy” Rating Reiterated at BTIG Research

Hyperfine (NASDAQ:HYPR)‘s stock had its “buy” rating restated by research analysts at BTIG Research in a note issued to investors on Monday, MarketBeat.com reports. They presently have a $2.00 price objective on the stock. BTIG Research’s price target points to a potential upside of 153.13% from the stock’s previous close.

A number of other equities analysts have also weighed in on HYPR. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperfine in a research note on Friday, July 17th. B. Riley Financial reaffirmed a “buy” rating and set a $1.60 target price (down from $2.00) on shares of Hyperfine in a report on Monday, August 10th. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Hyperfine currently has an average rating of “Hold” and a consensus target price of $2.03.

Hyperfine Stock Performance

HYPR opened at $0.79 on Monday. Hyperfine has a 12-month low of $0.78 and a 12-month high of $2.22. The company has a current ratio of 6.15, a quick ratio of 5.45 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $83.79 million, a PE ratio of -2.08 and a beta of 1.41. The firm has a 50 day moving average of $0.93 and a two-hundred day moving average of $1.20.

Hyperfine (NASDAQ:HYPR) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.09) EPS for the quarter, meeting the consensus estimate of ($0.09). Hyperfine had a negative net margin of 210.75% and a negative return on equity of 97.88%. The business had revenue of $3.90 million for the quarter, compared to the consensus estimate of $4.13 million. On average, analysts anticipate that Hyperfine will post -0.34 EPS for the current year.

Institutional Investors Weigh In On Hyperfine

Several institutional investors have recently bought and sold shares of HYPR. Bank of New York Mellon Corp acquired a new stake in shares of Hyperfine in the second quarter worth approximately $419,000. Renaissance Technologies LLC grew its holdings in shares of Hyperfine by 100.2% during the first quarter. Renaissance Technologies LLC now owns 730,233 shares of the company’s stock worth $789,000 after buying an additional 365,490 shares in the last quarter. Walleye Capital LLC raised its position in shares of Hyperfine by 3.4% in the first quarter. Walleye Capital LLC now owns 223,988 shares of the company’s stock valued at $242,000 after buying an additional 7,330 shares during the last quarter. EP Wealth Advisors LLC purchased a new position in shares of Hyperfine in the fourth quarter worth about $34,000. Finally, XTX Topco Ltd boosted its position in Hyperfine by 47.9% during the fourth quarter. XTX Topco Ltd now owns 80,735 shares of the company’s stock worth $79,000 after acquiring an additional 26,165 shares during the last quarter. 15.03% of the stock is currently owned by institutional investors and hedge funds.

Hyperfine Company Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.